Comparing effectiveness and tolerability of emtricitabine/tenofovir alafenamide (F/TAF) with emtricitabine/tenofovir disoproxil fumarate (F/TDF) in HIV-1 infected adult patients in routine clinical practice: a cross cohort analysis

被引：0

作者：

Esser, S. ^{[1
]}

Stellbrink, H-J ^{[2
]}

Heiken, H. ^{[3
]}

Meynard, J-L ^{[4
]}

Thorpe, D. ^{[5
]}

Schreiber, S. ^{[6
]}

Heinzkill, M. ^{[6
]}

Sahali, S. ^{[7
]}

Ramroth, H. ^{[5
]}

Haubrich, R. ^{[8
]}

机构：

[1] Univ Hosp Essen, Dept Venerol, Essen, Germany

[2] ICH Study Ctr, Hamburg, Germany

[3] Praxis Dres Kuhlmann Holm Heiken, Hannover, Germany

[4] Hop St Antoine, Paris, France

[5] Gilead Sci Europe Ltd, Uxbridge, Middx, England

[6] Gilead Sci GmbH, Munich, Germany

[7] Gilead Sci, Paris, France

[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

PE2/30

引用

页码：67 / 68

页数：2